Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Knee Surg Sports Traumatol Arthrosc. 2021 Jul;29(7):2134-2142. doi: 10.1007/s00167-020-06190-3. Epub 2020 Aug 3.
To conduct a systematic review of outcomes following primary arthroscopic repair of chronic massive rotator cuff tears (RCTs) and to assess clinical outcomes and rates of repair failure. The authors' preferred treatment algorithm is also provided.
Medline, Embase and PubMed were searched identifying articles pertaining to primary arthroscopic repair of chronic massive RCTs without the use of augmentation. Primary outcomes were patient-reported outcomes and the secondary outcome was the rate of repair failure. Outcome data were pooled and presented as well as assessment of study methodological quality. Data from studies reporting similar outcome measures were pooled when possible, and mean differences alongside confidence intervals and p values were reported, where appropriate.
Twenty-six studies (1405 participants) were included, with mean age of 62 years (range 52-69). The mean duration of symptoms pre-operatively was 31 months (range 6-40), and the mean follow-up time was 39 months (range 12-111). Complete repair was performed in 78% of patients and partial repair was performed in 22%. Both complete and partial repairs resulted in significant improvements with respect to pain, range of motion and functional outcome scores. The rate of repair failure for the total cohort was 36% at a mean follow-up of 31 months, and for the complete and partial repair subgroups the failure rate was 35% and 40%, respectively.
Arthroscopic repairs of chronic, massive RCTs, whether complete or partial, are associated with significant improvements in pain, function and objective outcome scores. The rate of repair failure is lower than previously reported, however, still high at 36%. The present paper finds that arthroscopic repair is still a viable treatment option for massive RCTs.
IV.
对慢性巨大肩袖撕裂(RCT)的初次关节镜修复后的结果进行系统回顾,并评估临床结果和修复失败率。作者还提供了首选的治疗方案。
检索 Medline、Embase 和 PubMed,以确定不使用增强剂的慢性巨大 RCT 的初次关节镜修复的文章。主要结果是患者报告的结果,次要结果是修复失败率。汇总并呈现了结果数据,并评估了研究方法学质量。对报告类似结果测量的研究的数据进行了汇总,如果可能,还报告了平均值差异以及置信区间和 p 值。
共纳入 26 项研究(1405 名参与者),平均年龄为 62 岁(范围 52-69 岁)。术前症状的平均持续时间为 31 个月(范围 6-40 个月),平均随访时间为 39 个月(范围 12-111 个月)。78%的患者进行了完全修复,22%的患者进行了部分修复。完全和部分修复都显著改善了疼痛、运动范围和功能结果评分。在平均 31 个月的随访中,总队列的修复失败率为 36%,完全修复亚组和部分修复亚组的失败率分别为 35%和 40%。
慢性巨大 RCT 的关节镜修复,无论是完全还是部分修复,都与疼痛、功能和客观结果评分的显著改善相关。修复失败率低于先前报告,但仍高达 36%。本文发现,关节镜修复仍然是巨大 RCT 的一种可行的治疗选择。
IV。